Cannovum Cannabis is rated "Neutral" based on sentiment and buzz in social media platforms. There have been no significant changes in the sentiment or frequency of discussions about the stock in the past four weeks. The stock is neither overbought nor oversold based on the Relative Strength Index (RSI) of the last 7 days and the RSI25. The 7-day RSI indicates that the stock is overbought, while the RSI25 suggests it is neither overbought nor oversold, resulting in a "Neutral" rating. From a technical analysis perspective, the stock is rated "Poor" as it deviates significantly from the average closing price of the last 200 and 50 trading days. In terms of investor sentiment, discussions on social media platforms have been mostly neutral, leading to a "Neutral" rating. Overall, Cannovum Cannabis is deemed to be appropriately rated as "Neutral" in terms of investor sentiment.
Kaufen, halten oder verkaufen – Ihre Cannovum-Analyse vom 28.11. liefert die Antwort:
Wie wird sich Cannovum jetzt weiter entwickeln? Lohnt sich ein Einstieg oder sollten Anleger lieber verkaufen? Die Antworten auf diese Fragen und warum Sie jetzt handeln müssen, erfahren Sie in der aktuellen Cannovum-Analyse.
Cannovum: Kaufen oder verkaufen? Hier weiterlesen...
Kurs | Vortag | Veränderung | Datum/Zeit | |
1,97 € | 2,075 € | -0,105 € | -5,06% | 06.12./08:00 |
ISIN | WKN | Jahreshoch | Jahrestief | |
SE0017084759 | A3C955 | 3,16 € | 1,48 € |
![]() |